[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription.
Kaanders JHAM, Bussink J, Aarntzen EHJG, Braam P, Rütten H, van der Maazen RWM, Verheij M, van den Bosch S.
Semin Radiat Oncol. 2023 Jul;33(3):287-297. doi: 10.1016/j.semradonc.2023.03.006.
18F-FDG PET/CT for the evaluation of male breast cancer: a systematic review.
Dondi F, Albano D, Giubbini R, Bertagna F.
Nucl Med Commun. 2022 Feb 1;43(2):123-128. doi: 10.1097/MNM.0000000000001508.
18F-FDG-PET/CT scanning-clinical usefulness beyond cancer.
Donnelly SC.
QJM. 2018 Sep 1;111(9):593. doi: 10.1093/qjmed/hcy184.
Hyperglycemia and 18F-FDG PET/CT, issues and problem solving: a literature review.
Finessi M, Bisi G, Deandreis D.
Acta Diabetol. 2020 Mar;57(3):253-262. doi: 10.1007/s00592-019-01385-8. Epub 2019 Jul 15.
18F-FDG-PET/CT in malignant mesothelioma.
Fuccio C, Spinapolice EG, Ferretti A, Castellucci P, Marzola MC, Trifirò G, Rubello D.
Biomed Pharmacother. 2013 Jul;67(6):539-42. doi: 10.1016/j.biopha.2013.01.008. Epub 2013 Feb 18.
18F-FDG PET/CT in Hyalinized Cholecystitis.
Arslan E, Yardimci AH, Yarikkaya E, Alçin G, Çermik TF.
Clin Nucl Med. 2021 Apr 1;46(4):e228-e230. doi: 10.1097/RLU.0000000000003268.
18F-FDG PET-CT scan muscle uptake: pathologic?
Dollinger A, Prati C, Wendling D, Verhoeven F.
Rheumatology (Oxford). 2023 Aug 1;62(8):e255-e256. doi: 10.1093/rheumatology/kead003.
18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging.
Caresia Aroztegui AP, García Vicente AM, Alvarez Ruiz S, Delgado Bolton RC, Orcajo Rincon J, Garcia Garzon JR, de Arcocha Torres M, Garcia-Velloso MJ; Oncology Task Force of the Spanish Society of Nuclear Medicine and Molecular Imaging.
Tumour Biol. 2017 Oct;39(10):1010428317728285. doi: 10.1177/1010428317728285.
18F- FDG PET/CT in reclassifying the probable diagnosis of IE - A review.
Sathyamurthy I, Elangovan I.
Indian Heart J. 2024 Jan-Feb;76(1):10-15. doi: 10.1016/j.ihj.2024.01.003. Epub 2024 Jan 5.
Brain 18F-FDG PET in Cowden Syndrome.
Grangeret J, Frismand S, Muller M, Renaud M, Verger A.
Clin Nucl Med. 2022 Feb 1;47(2):e118-e119. doi: 10.1097/RLU.0000000000004025.
